SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth-Reference-Cited by-同舟云学术

SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth

Published:2013-04-30 Issue:9 Volume:37 Page:929-939
ISSN:1065-6995
Container-title:Cell Biology International
language:en
Short-container-title:Cell Biol Int

Author:

Jin Tao¹,Fu Jie²,Feng Xiao-Jun³,Wang Shou-Mei³,Huang Xue³,Zhu Ming-Hua⁴,Zhang Shu-Hui³

Affiliation:

1. The First Department of Surgery; Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Zhejiang University of Traditional Chinese Medicine; Hangzhou, P.R.; China

2. Department of Radiation Oncology; Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University; Shanghai, P.R.; China

3. Department of Pathology; Yueyang Hospital, Shanghai University of Traditional Chinese Medicine; Shanghai, P.R.; China

4. Department of Pathology; Changhai Hospital and Institute of Liver Diseases, Second Military Medical University; Shanghai, P.R.; China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cbin.10113/fullpdf

Reference36 articles.

1. Prolactin and estrogen up-regulate carboxypeptidase-D to promote nitric oxide production and survival of mcf-7 breast cancer cells;Abdelmagid;Endocrinology,2008

2. RNA interference and the use of small interfering RNA to study gene function in mammalian systems;Bantounas;J Mol Endocrinol,2004

3. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis;Calvisi;Gastroenterology,2009

4. Differential regulation and localization of carboxypeptidase D and carboxypeptidase E in human and mouse β-cells;Chu;Islets,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small interference (RNAi) technique: Exploring its clinical applications, benefits and limitations;European Journal of Clinical Investigation;2023-06-13

2. Serum Carboxypeptidase N1 Serves as a Potential Biomarker Complementing CA15-3 for Breast Cancer;Anti-Cancer Agents in Medicinal Chemistry;2020-11-12

3. Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid Leukemia;Cancers;2019-12-05

4. Substrate specificity of human metallocarboxypeptidase D: Comparison of the two active carboxypeptidase domains;PLOS ONE;2017-11-13

5. Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro;Breast Cancer Research and Treatment;2017-03-31